EQT Fund Management S.a r.l.

Position in OCS — Oculis Holding AG

CIK 1834239 LUXEMBOURG, N4

Position in OCS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$96,400,577

-$60,488,240 QoQ

Shares Held

6,950,294

+17.8% QoQ

Ownership

12.5%

of shares outstanding

% of Portfolio

11.18%

of 13F equity value

Holder Rank

of 59 holders

Holding Since

Sep 2025

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EQT Fund Management S.a r.l. holds $351,848,291 across 4 Biotechnology names. OCS ranks #2 (27.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PHVS	Pharvaris N.V.	3,424,609	$118,422,979
2	OCS	Oculis Holding AG This page	6,950,294	$96,400,577
3	EVMN	Evommune, Inc.	5,288,313	$70,281,679
4	AGMB	Agomab Therapeutics NV	5,141,992	$66,743,056

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$96,400,577	6,950,294	+17.8%	Shares	Sole	2026-08-13
2026-03-31	$156,888,817	5,900,294	0.0%	Shares	Sole	2026-05-14
2025-12-31	$117,828,871	5,900,294	0.0%	Shares	Sole	2026-02-11
2025-09-30	$103,727,168	5,900,294	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.